Global Respiratory Disorders Drug Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 111
Inquire Before Buying

Respiratory Disorders Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Respiratory Disorders Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Capsule

- Suspension Agent

- Injection

- Gas (Powder) Mist

- Tablets

- Solution

- Granules

- Dropping Pill

- Patch

- Other

Segment by Application

- Clearing Away Heat And Detoxifying Drugs

- Expectorant

- Cold Medicine

- Antiasthmatic

- COPD Treatment Medicine

- Cough Medicine

- Respiratory Stimulant

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- AstraZeneca

- MSD

- Boehringer Ingelheim

- Biogen

- Pfizer

- Teva

- Novartis

- Johnson & Johnson

- Eli Lilly

- Otsuka

- Merck

- Takeda

- FibroGen

- Amgen

- Dr. Reddy's Laboratories

- Dainippon Sumitomo

- Abbott

- Horizon Pharma

- Zambon

- Moehs

- Pharmazell

- Nippon Rika

- Chengyi Pharma

- Wuhan Grand Hoyo

- Manus Aktteva Biopharma

- Beijing Jiuhe Pharmaceutical

- Daiichi Sankyo Pharmaceutical

- Sinopharm

- CTTQ

- Yangtze River Pharmaceutical Group

Global Respiratory Disorders Drug Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Disorders Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Capsule
1.2.3 Suspension Agent
1.2.4 Injection
1.2.5 Gas (Powder) Mist
1.2.6 Tablets
1.2.7 Solution
1.2.8 Granules
1.2.9 Dropping Pill
1.2.10 Patch
1.2.11 Other
1.3 Market by Application
1.3.1 Global Respiratory Disorders Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Clearing Away Heat And Detoxifying Drugs
1.3.3 Expectorant
1.3.4 Cold Medicine
1.3.5 Antiasthmatic
1.3.6 COPD Treatment Medicine
1.3.7 Cough Medicine
1.3.8 Respiratory Stimulant
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Disorders Drug Market Perspective (2017-2028)
2.2 Respiratory Disorders Drug Growth Trends by Region
2.2.1 Respiratory Disorders Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Respiratory Disorders Drug Historic Market Size by Region (2017-2022)
2.2.3 Respiratory Disorders Drug Forecasted Market Size by Region (2023-2028)
2.3 Respiratory Disorders Drug Market Dynamics
2.3.1 Respiratory Disorders Drug Industry Trends
2.3.2 Respiratory Disorders Drug Market Drivers
2.3.3 Respiratory Disorders Drug Market Challenges
2.3.4 Respiratory Disorders Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Disorders Drug Players by Revenue
3.1.1 Global Top Respiratory Disorders Drug Players by Revenue (2017-2022)
3.1.2 Global Respiratory Disorders Drug Revenue Market Share by Players (2017-2022)
3.2 Global Respiratory Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Disorders Drug Revenue
3.4 Global Respiratory Disorders Drug Market Concentration Ratio
3.4.1 Global Respiratory Disorders Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Disorders Drug Revenue in 2021
3.5 Respiratory Disorders Drug Key Players Head office and Area Served
3.6 Key Players Respiratory Disorders Drug Product Solution and Service
3.7 Date of Enter into Respiratory Disorders Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Disorders Drug Breakdown Data by Type
4.1 Global Respiratory Disorders Drug Historic Market Size by Type (2017-2022)
4.2 Global Respiratory Disorders Drug Forecasted Market Size by Type (2023-2028)
5 Respiratory Disorders Drug Breakdown Data by Application
5.1 Global Respiratory Disorders Drug Historic Market Size by Application (2017-2022)
5.2 Global Respiratory Disorders Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Respiratory Disorders Drug Market Size (2017-2028)
6.2 North America Respiratory Disorders Drug Market Size by Country (2017-2022)
6.3 North America Respiratory Disorders Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Respiratory Disorders Drug Market Size (2017-2028)
7.2 Europe Respiratory Disorders Drug Market Size by Country (2017-2022)
7.3 Europe Respiratory Disorders Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Disorders Drug Market Size (2017-2028)
8.2 Asia-Pacific Respiratory Disorders Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Respiratory Disorders Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Respiratory Disorders Drug Market Size (2017-2028)
9.2 Latin America Respiratory Disorders Drug Market Size by Country (2017-2022)
9.3 Latin America Respiratory Disorders Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Disorders Drug Market Size (2017-2028)
10.2 Middle East & Africa Respiratory Disorders Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Respiratory Disorders Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Respiratory Disorders Drug Introduction
11.1.4 AstraZeneca Revenue in Respiratory Disorders Drug Business (2017-2022)
11.1.5 AstraZeneca Recent Development
11.2 MSD
11.2.1 MSD Company Detail
11.2.2 MSD Business Overview
11.2.3 MSD Respiratory Disorders Drug Introduction
11.2.4 MSD Revenue in Respiratory Disorders Drug Business (2017-2022)
11.2.5 MSD Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Respiratory Disorders Drug Introduction
11.3.4 Boehringer Ingelheim Revenue in Respiratory Disorders Drug Business (2017-2022)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Biogen
11.4.1 Biogen Company Detail
11.4.2 Biogen Business Overview
11.4.3 Biogen Respiratory Disorders Drug Introduction
11.4.4 Biogen Revenue in Respiratory Disorders Drug Business (2017-2022)
11.4.5 Biogen Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Respiratory Disorders Drug Introduction
11.5.4 Pfizer Revenue in Respiratory Disorders Drug Business (2017-2022)
11.5.5 Pfizer Recent Development
11.6 Teva
11.6.1 Teva Company Detail
11.6.2 Teva Business Overview
11.6.3 Teva Respiratory Disorders Drug Introduction
11.6.4 Teva Revenue in Respiratory Disorders Drug Business (2017-2022)
11.6.5 Teva Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Respiratory Disorders Drug Introduction
11.7.4 Novartis Revenue in Respiratory Disorders Drug Business (2017-2022)
11.7.5 Novartis Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Respiratory Disorders Drug Introduction
11.8.4 Johnson & Johnson Revenue in Respiratory Disorders Drug Business (2017-2022)
11.8.5 Johnson & Johnson Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Respiratory Disorders Drug Introduction
11.9.4 Eli Lilly Revenue in Respiratory Disorders Drug Business (2017-2022)
11.9.5 Eli Lilly Recent Development
11.10 Otsuka
11.10.1 Otsuka Company Detail
11.10.2 Otsuka Business Overview
11.10.3 Otsuka Respiratory Disorders Drug Introduction
11.10.4 Otsuka Revenue in Respiratory Disorders Drug Business (2017-2022)
11.10.5 Otsuka Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Respiratory Disorders Drug Introduction
11.11.4 Merck Revenue in Respiratory Disorders Drug Business (2017-2022)
11.11.5 Merck Recent Development
11.12 Takeda
11.12.1 Takeda Company Detail
11.12.2 Takeda Business Overview
11.12.3 Takeda Respiratory Disorders Drug Introduction
11.12.4 Takeda Revenue in Respiratory Disorders Drug Business (2017-2022)
11.12.5 Takeda Recent Development
11.13 FibroGen
11.13.1 FibroGen Company Detail
11.13.2 FibroGen Business Overview
11.13.3 FibroGen Respiratory Disorders Drug Introduction
11.13.4 FibroGen Revenue in Respiratory Disorders Drug Business (2017-2022)
11.13.5 FibroGen Recent Development
11.14 Amgen
11.14.1 Amgen Company Detail
11.14.2 Amgen Business Overview
11.14.3 Amgen Respiratory Disorders Drug Introduction
11.14.4 Amgen Revenue in Respiratory Disorders Drug Business (2017-2022)
11.14.5 Amgen Recent Development
11.15 Dr. Reddy's Laboratories
11.15.1 Dr. Reddy's Laboratories Company Detail
11.15.2 Dr. Reddy's Laboratories Business Overview
11.15.3 Dr. Reddy's Laboratories Respiratory Disorders Drug Introduction
11.15.4 Dr. Reddy's Laboratories Revenue in Respiratory Disorders Drug Business (2017-2022)
11.15.5 Dr. Reddy's Laboratories Recent Development
11.16 Dainippon Sumitomo
11.16.1 Dainippon Sumitomo Company Detail
11.16.2 Dainippon Sumitomo Business Overview
11.16.3 Dainippon Sumitomo Respiratory Disorders Drug Introduction
11.16.4 Dainippon Sumitomo Revenue in Respiratory Disorders Drug Business (2017-2022)
11.16.5 Dainippon Sumitomo Recent Development
11.17 Abbott
11.17.1 Abbott Company Detail
11.17.2 Abbott Business Overview
11.17.3 Abbott Respiratory Disorders Drug Introduction
11.17.4 Abbott Revenue in Respiratory Disorders Drug Business (2017-2022)
11.17.5 Abbott Recent Development
11.18 Horizon Pharma
11.18.1 Horizon Pharma Company Detail
11.18.2 Horizon Pharma Business Overview
11.18.3 Horizon Pharma Respiratory Disorders Drug Introduction
11.18.4 Horizon Pharma Revenue in Respiratory Disorders Drug Business (2017-2022)
11.18.5 Horizon Pharma Recent Development
11.19 Zambon
11.19.1 Zambon Company Detail
11.19.2 Zambon Business Overview
11.19.3 Zambon Respiratory Disorders Drug Introduction
11.19.4 Zambon Revenue in Respiratory Disorders Drug Business (2017-2022)
11.19.5 Zambon Recent Development
11.20 Moehs
11.20.1 Moehs Company Detail
11.20.2 Moehs Business Overview
11.20.3 Moehs Respiratory Disorders Drug Introduction
11.20.4 Moehs Revenue in Respiratory Disorders Drug Business (2017-2022)
11.20.5 Moehs Recent Development
11.21 Pharmazell
11.21.1 Pharmazell Company Detail
11.21.2 Pharmazell Business Overview
11.21.3 Pharmazell Respiratory Disorders Drug Introduction
11.21.4 Pharmazell Revenue in Respiratory Disorders Drug Business (2017-2022)
11.21.5 Pharmazell Recent Development
11.22 Nippon Rika
11.22.1 Nippon Rika Company Detail
11.22.2 Nippon Rika Business Overview
11.22.3 Nippon Rika Respiratory Disorders Drug Introduction
11.22.4 Nippon Rika Revenue in Respiratory Disorders Drug Business (2017-2022)
11.22.5 Nippon Rika Recent Development
11.23 Chengyi Pharma
11.23.1 Chengyi Pharma Company Detail
11.23.2 Chengyi Pharma Business Overview
11.23.3 Chengyi Pharma Respiratory Disorders Drug Introduction
11.23.4 Chengyi Pharma Revenue in Respiratory Disorders Drug Business (2017-2022)
11.23.5 Chengyi Pharma Recent Development
11.24 Wuhan Grand Hoyo
11.24.1 Wuhan Grand Hoyo Company Detail
11.24.2 Wuhan Grand Hoyo Business Overview
11.24.3 Wuhan Grand Hoyo Respiratory Disorders Drug Introduction
11.24.4 Wuhan Grand Hoyo Revenue in Respiratory Disorders Drug Business (2017-2022)
11.24.5 Wuhan Grand Hoyo Recent Development
11.25 Manus Aktteva Biopharma
11.25.1 Manus Aktteva Biopharma Company Detail
11.25.2 Manus Aktteva Biopharma Business Overview
11.25.3 Manus Aktteva Biopharma Respiratory Disorders Drug Introduction
11.25.4 Manus Aktteva Biopharma Revenue in Respiratory Disorders Drug Business (2017-2022)
11.25.5 Manus Aktteva Biopharma Recent Development
11.26 Beijing Jiuhe Pharmaceutical
11.26.1 Beijing Jiuhe Pharmaceutical Company Detail
11.26.2 Beijing Jiuhe Pharmaceutical Business Overview
11.26.3 Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Introduction
11.26.4 Beijing Jiuhe Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022)
11.26.5 Beijing Jiuhe Pharmaceutical Recent Development
11.27 Daiichi Sankyo Pharmaceutical
11.27.1 Daiichi Sankyo Pharmaceutical Company Detail
11.27.2 Daiichi Sankyo Pharmaceutical Business Overview
11.27.3 Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Introduction
11.27.4 Daiichi Sankyo Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022)
11.27.5 Daiichi Sankyo Pharmaceutical Recent Development
11.28 Sinopharm
11.28.1 Sinopharm Company Detail
11.28.2 Sinopharm Business Overview
11.28.3 Sinopharm Respiratory Disorders Drug Introduction
11.28.4 Sinopharm Revenue in Respiratory Disorders Drug Business (2017-2022)
11.28.5 Sinopharm Recent Development
11.29 CTTQ
11.29.1 CTTQ Company Detail
11.29.2 CTTQ Business Overview
11.29.3 CTTQ Respiratory Disorders Drug Introduction
11.29.4 CTTQ Revenue in Respiratory Disorders Drug Business (2017-2022)
11.29.5 CTTQ Recent Development
11.30 Yangtze River Pharmaceutical Group
11.30.1 Yangtze River Pharmaceutical Group Company Detail
11.30.2 Yangtze River Pharmaceutical Group Business Overview
11.30.3 Yangtze River Pharmaceutical Group Respiratory Disorders Drug Introduction
11.30.4 Yangtze River Pharmaceutical Group Revenue in Respiratory Disorders Drug Business (2017-2022)
11.30.5 Yangtze River Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Respiratory Disorders Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Capsule
Table 3. Key Players of Suspension Agent
Table 4. Key Players of Injection
Table 5. Key Players of Gas (Powder) Mist
Table 6. Key Players of Tablets
Table 7. Key Players of Solution
Table 8. Key Players of Granules
Table 9. Key Players of Dropping Pill
Table 10. Key Players of Patch
Table 11. Key Players of Other
Table 12. Global Respiratory Disorders Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 13. Global Respiratory Disorders Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 14. Global Respiratory Disorders Drug Market Size by Region (2017-2022) & (US$ Million)
Table 15. Global Respiratory Disorders Drug Market Share by Region (2017-2022)
Table 16. Global Respiratory Disorders Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 17. Global Respiratory Disorders Drug Market Share by Region (2023-2028)
Table 18. Respiratory Disorders Drug Market Trends
Table 19. Respiratory Disorders Drug Market Drivers
Table 20. Respiratory Disorders Drug Market Challenges
Table 21. Respiratory Disorders Drug Market Restraints
Table 22. Global Respiratory Disorders Drug Revenue by Players (2017-2022) & (US$ Million)
Table 23. Global Respiratory Disorders Drug Market Share by Players (2017-2022)
Table 24. Global Top Respiratory Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Disorders Drug as of 2021)
Table 25. Ranking of Global Top Respiratory Disorders Drug Companies by Revenue (US$ Million) in 2021
Table 26. Global 5 Largest Players Market Share by Respiratory Disorders Drug Revenue (CR5 and HHI) & (2017-2022)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Respiratory Disorders Drug Product Solution and Service
Table 29. Date of Enter into Respiratory Disorders Drug Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Respiratory Disorders Drug Market Size by Type (2017-2022) & (US$ Million)
Table 32. Global Respiratory Disorders Drug Revenue Market Share by Type (2017-2022)
Table 33. Global Respiratory Disorders Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 34. Global Respiratory Disorders Drug Revenue Market Share by Type (2023-2028)
Table 35. Global Respiratory Disorders Drug Market Size by Application (2017-2022) & (US$ Million)
Table 36. Global Respiratory Disorders Drug Revenue Market Share by Application (2017-2022)
Table 37. Global Respiratory Disorders Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 38. Global Respiratory Disorders Drug Revenue Market Share by Application (2023-2028)
Table 39. North America Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia-Pacific Respiratory Disorders Drug Market Size by Region (2017-2022) & (US$ Million)
Table 44. Asia-Pacific Respiratory Disorders Drug Market Size by Region (2023-2028) & (US$ Million)
Table 45. Latin America Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 46. Latin America Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 47. Middle East & Africa Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 48. Middle East & Africa Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 49. AstraZeneca Company Detail
Table 50. AstraZeneca Business Overview
Table 51. AstraZeneca Respiratory Disorders Drug Product
Table 52. AstraZeneca Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 53. AstraZeneca Recent Development
Table 54. MSD Company Detail
Table 55. MSD Business Overview
Table 56. MSD Respiratory Disorders Drug Product
Table 57. MSD Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 58. MSD Recent Development
Table 59. Boehringer Ingelheim Company Detail
Table 60. Boehringer Ingelheim Business Overview
Table 61. Boehringer Ingelheim Respiratory Disorders Drug Product
Table 62. Boehringer Ingelheim Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 63. Boehringer Ingelheim Recent Development
Table 64. Biogen Company Detail
Table 65. Biogen Business Overview
Table 66. Biogen Respiratory Disorders Drug Product
Table 67. Biogen Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 68. Biogen Recent Development
Table 69. Pfizer Company Detail
Table 70. Pfizer Business Overview
Table 71. Pfizer Respiratory Disorders Drug Product
Table 72. Pfizer Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Teva Company Detail
Table 75. Teva Business Overview
Table 76. Teva Respiratory Disorders Drug Product
Table 77. Teva Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 78. Teva Recent Development
Table 79. Novartis Company Detail
Table 80. Novartis Business Overview
Table 81. Novartis Respiratory Disorders Drug Product
Table 82. Novartis Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Johnson & Johnson Company Detail
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Respiratory Disorders Drug Product
Table 87. Johnson & Johnson Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Eli Lilly Company Detail
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Respiratory Disorders Drug Product
Table 92. Eli Lilly Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 93. Eli Lilly Recent Development
Table 94. Otsuka Company Detail
Table 95. Otsuka Business Overview
Table 96. Otsuka Respiratory Disorders Drug Product
Table 97. Otsuka Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 98. Otsuka Recent Development
Table 99. Merck Company Detail
Table 100. Merck Business Overview
Table 101. Merck Respiratory Disorders DrugProduct
Table 102. Merck Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 103. Merck Recent Development
Table 104. Takeda Company Detail
Table 105. Takeda Business Overview
Table 106. Takeda Respiratory Disorders DrugProduct
Table 107. Takeda Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 108. Takeda Recent Development
Table 109. FibroGen Company Detail
Table 110. FibroGen Business Overview
Table 111. FibroGen Respiratory Disorders DrugProduct
Table 112. FibroGen Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 113. FibroGen Recent Development
Table 114. Amgen Company Detail
Table 115. Amgen Business Overview
Table 116. Amgen Respiratory Disorders DrugProduct
Table 117. Amgen Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 118. Amgen Recent Development
Table 119. Dr. Reddy's Laboratories Company Detail
Table 120. Dr. Reddy's Laboratories Business Overview
Table 121. Dr. Reddy's Laboratories Respiratory Disorders DrugProduct
Table 122. Dr. Reddy's Laboratories Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 123. Dr. Reddy's Laboratories Recent Development
Table 124. Dainippon Sumitomo Company Detail
Table 125. Dainippon Sumitomo Business Overview
Table 126. Dainippon Sumitomo Respiratory Disorders DrugProduct
Table 127. Dainippon Sumitomo Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 128. Dainippon Sumitomo Recent Development
Table 129. Abbott Company Detail
Table 130. Abbott Business Overview
Table 131. Abbott Respiratory Disorders DrugProduct
Table 132. Abbott Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 133. Abbott Recent Development
Table 134. Horizon Pharma Company Detail
Table 135. Horizon Pharma Business Overview
Table 136. Horizon Pharma Respiratory Disorders DrugProduct
Table 137. Horizon Pharma Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 138. Horizon Pharma Recent Development
Table 139. Zambon Company Detail
Table 140. Zambon Business Overview
Table 141. Zambon Respiratory Disorders DrugProduct
Table 142. Zambon Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 143. Zambon Recent Development
Table 144. Moehs Company Detail
Table 145. Moehs Business Overview
Table 146. Moehs Respiratory Disorders DrugProduct
Table 147. Moehs Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 148. Moehs Recent Development
Table 149. Pharmazell Company Detail
Table 150. Pharmazell Business Overview
Table 151. Pharmazell Respiratory Disorders DrugProduct
Table 152. Pharmazell Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 153. Pharmazell Recent Development
Table 154. Nippon Rika Company Detail
Table 155. Nippon Rika Business Overview
Table 156. Nippon Rika Respiratory Disorders DrugProduct
Table 157. Nippon Rika Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 158. Nippon Rika Recent Development
Table 159. Chengyi Pharma Company Detail
Table 160. Chengyi Pharma Business Overview
Table 161. Chengyi Pharma Respiratory Disorders DrugProduct
Table 162. Chengyi Pharma Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 163. Chengyi Pharma Recent Development
Table 164. Wuhan Grand Hoyo Company Detail
Table 165. Wuhan Grand Hoyo Business Overview
Table 166. Wuhan Grand Hoyo Respiratory Disorders DrugProduct
Table 167. Wuhan Grand Hoyo Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 168. Wuhan Grand Hoyo Recent Development
Table 169. Manus Aktteva Biopharma Company Detail
Table 170. Manus Aktteva Biopharma Business Overview
Table 171. Manus Aktteva Biopharma Respiratory Disorders DrugProduct
Table 172. Manus Aktteva Biopharma Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 173. Manus Aktteva Biopharma Recent Development
Table 174. Beijing Jiuhe Pharmaceutical Company Detail
Table 175. Beijing Jiuhe Pharmaceutical Business Overview
Table 176. Beijing Jiuhe Pharmaceutical Respiratory Disorders DrugProduct
Table 177. Beijing Jiuhe Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 178. Beijing Jiuhe Pharmaceutical Recent Development
Table 179. Daiichi Sankyo Pharmaceutical Company Detail
Table 180. Daiichi Sankyo Pharmaceutical Business Overview
Table 181. Daiichi Sankyo Pharmaceutical Respiratory Disorders DrugProduct
Table 182. Daiichi Sankyo Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 183. Daiichi Sankyo Pharmaceutical Recent Development
Table 184. Sinopharm Company Detail
Table 185. Sinopharm Business Overview
Table 186. Sinopharm Respiratory Disorders DrugProduct
Table 187. Sinopharm Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 188. Sinopharm Recent Development
Table 189. CTTQ Company Detail
Table 190. CTTQ Business Overview
Table 191. CTTQ Respiratory Disorders DrugProduct
Table 192. CTTQ Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 193. CTTQ Recent Development
Table 194. Yangtze River Pharmaceutical Group Company Detail
Table 195. Yangtze River Pharmaceutical Group Business Overview
Table 196. Yangtze River Pharmaceutical Group Respiratory Disorders DrugProduct
Table 197. Yangtze River Pharmaceutical Group Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 198. Yangtze River Pharmaceutical Group Recent Development
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Disorders Drug Market Share by Type: 2021 VS 2028
Figure 2. Capsule Features
Figure 3. Suspension Agent Features
Figure 4. Injection Features
Figure 5. Gas (Powder) Mist Features
Figure 6. Tablets Features
Figure 7. Solution Features
Figure 8. Granules Features
Figure 9. Dropping Pill Features
Figure 10. Patch Features
Figure 11. Other Features
Figure 12. Global Respiratory Disorders Drug Market Share by Application in 2021 & 2028
Figure 13. Clearing Away Heat And Detoxifying Drugs Case Studies
Figure 14. Expectorant Case Studies
Figure 15. Cold Medicine Case Studies
Figure 16. Antiasthmatic Case Studies
Figure 17. COPD Treatment Medicine Case Studies
Figure 18. Cough Medicine Case Studies
Figure 19. Respiratory Stimulant Case Studies
Figure 20. Other Case Studies
Figure 21. Respiratory Disorders Drug Report Years Considered
Figure 22. Global Respiratory Disorders Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 23. Global Respiratory Disorders Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 24. Global Respiratory Disorders Drug Market Share by Region: 2021 VS 2028
Figure 25. Global Respiratory Disorders Drug Market Share by Players in 2021
Figure 26. Global Top Respiratory Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Disorders Drug as of 2021)
Figure 27. The Top 10 and 5 Players Market Share by Respiratory Disorders Drug Revenue in 2021
Figure 28. North America Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. North America Respiratory Disorders Drug Market Share by Country (2017-2028)
Figure 30. United States Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Canada Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Europe Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Europe Respiratory Disorders Drug Market Share by Country (2017-2028)
Figure 34. Germany Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. France Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. U.K. Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Italy Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Russia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Nordic Countries Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Asia-Pacific Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Asia-Pacific Respiratory Disorders Drug Market Share by Region (2017-2028)
Figure 42. China Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Japan Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. South Korea Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Southeast Asia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. India Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Australia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Latin America Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Latin America Respiratory Disorders Drug Market Share by Country (2017-2028)
Figure 50. Mexico Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Respiratory Disorders Drug Market Share by Country (2017-2028)
Figure 54. Turkey Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. AstraZeneca Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 57. MSD Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 58. Boehringer Ingelheim Rev
  • Global Federated Learning Solution Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 90
    Federated Learning Solution market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Federated Learning Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Data Privacy and Security Management - Risk Management ......
  • Global AI For IT Operations Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 82
    AI For IT Operations market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global AI For IT Operations market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Cloud Deployment - Local Deployment Segment by Application......
  • Global AI In Remote Patient Monitoring Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 92
    AI In Remote Patient Monitoring market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global AI In Remote Patient Monitoring market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Whole Exome - Whole Genome - Vital Monitors......
  • Global Corrosion Testing Services Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 88
    Corrosion Testing Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Corrosion Testing Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Metallic - Non-Metallic Segment by Application......
  • Global FTIR Oil Condition Monitoring Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 85
    FTIR Oil Condition Monitoring market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global FTIR Oil Condition Monitoring market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - On-field Services - Off-field Services Seg......
  • Global Mobile VoIP Apps Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 80
    Mobile VoIP Apps market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Mobile VoIP Apps market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - International VoIP - Domestic VoIP Segment by Application - C......
  • Global Smart Shelves Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 110
    Smart Shelves market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Smart Shelves market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Hardware - Software - Services Segment by Application - SMEs......
  • Global AR and VR in Tourism Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 86
    AR and VR in Tourism market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global AR and VR in Tourism market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Solution - Services Segment by Application - 3D Model......
  • Global AI in Travel and Hospitality Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 85
    AI in Travel and Hospitality market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global AI in Travel and Hospitality market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Machine Learning - Natural Language Processing - Cha......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs